Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan; Department of General Internal Medicine, Kanazawa Medical University, Ishikawa, Japan.
Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan.
Neurosci Biobehav Rev. 2024 Dec;167:105900. doi: 10.1016/j.neubiorev.2024.105900. Epub 2024 Sep 17.
Schizophrenia and Alzheimer's disease (AD) are distinct neurodegenerative disorders characterized by progressive cognitive deficits and structural alterations in the brain. Schizophrenia typically emerges in adolescence or early adulthood with symptoms such as hallucinations, delusions, and cognitive impairments, whereas AD primarily affects elderly individuals, causing progressive memory loss, cognitive decline, and behavioral changes. Delusional disorder, which often emerges later in life, shares some features with schizophrenia and is considered a schizophrenia spectrum disorder. Patients with schizophrenia or delusional disorder, particularly women and those aged 65 years or older, have an increased risk of developing AD later in life. In contrast, approximately 30 % of AD patients exhibit psychotic symptoms, which accelerate cognitive decline and worsen health outcomes. This integrative review explored the genetic overlap between schizophrenia spectrum disorders and AD to identify potential shared genetic factors. The genetic correlations between schizophrenia and AD were weak but positive (r=0.03-0.10). Polygenic risk scores (PRSs) for schizophrenia and AD indicate some genetic predisposition, although findings are inconsistent among studies; e.g., PRS-schizophrenia or PRS-AD were associated with the risk of developing psychosis in patients with AD. A higher PRS for various developmental and psychiatric disorders was correlated with an earlier age at onset of schizophrenia. Research gaps include the need for studies on the impacts of PRS-AD on the risk of schizophrenia, genetic correlations between later-onset delusional disorder and AD, and genetic relationships between AD and late-onset schizophrenia (LOS) with a greater risk of progressing to AD. Further investigation into these genetic overlaps is crucial to enhance prevention, treatment, and prognosis for affected patients.
精神分裂症和阿尔茨海默病(AD)是两种不同的神经退行性疾病,其特征是大脑认知功能逐渐下降和结构改变。精神分裂症通常在青少年或成年早期出现,症状包括幻觉、妄想和认知障碍,而 AD 主要影响老年人,导致进行性记忆丧失、认知能力下降和行为改变。妄想障碍通常在晚年出现,与精神分裂症有一些共同特征,被认为是精神分裂症谱系障碍。精神分裂症或妄想障碍患者,特别是女性和 65 岁以上的患者,晚年患 AD 的风险增加。相比之下,约 30%的 AD 患者出现精神病症状,加速认知能力下降并导致健康状况恶化。本综述探讨了精神分裂症谱系障碍和 AD 之间的遗传重叠,以确定潜在的共同遗传因素。精神分裂症和 AD 之间的遗传相关性较弱但为正(r=0.03-0.10)。精神分裂症和 AD 的多基因风险评分(PRS)表明存在一些遗传易感性,但研究结果不一致;例如,AD 患者的 PRS-精神分裂症或 PRS-AD 与发生精神病的风险相关。各种发育和精神障碍的更高 PRS 与精神分裂症的发病年龄更早相关。研究空白包括需要研究 PRS-AD 对精神分裂症风险的影响、晚发性妄想障碍与 AD 之间的遗传相关性以及 AD 与晚发性精神分裂症(LOS)之间的遗传关系,后者进展为 AD 的风险更高。进一步研究这些遗传重叠对于增强受影响患者的预防、治疗和预后至关重要。